Stock Events

Stock Events

Prelude Therapeutics (PRLD) Q3 2026 Earnings

11AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-0.44

-0.34

-0.23

-0.13

Details

Expected EPS

-0.196667

Actual EPS

-0.14

Surprise EPS

0.06

Surprise Percent

+28.81%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.14 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.